Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Primary Care

Building a Rare Disease Care Team

At a Glance

Because fucosidosis can affect multiple body systems, care usually requires a metabolic geneticist, primary care clinician, and specialists for brain, breathing, nutrition, bones, hearing, vision, and therapies. Organized records and a named coordinator help the team communicate.

Because fucosidosis is an ultra-rare condition that affects multiple systems in the body, care cannot be managed by a single doctor. Instead, you will need to assemble a multidisciplinary care team—a group of specialists who work together to monitor health and manage symptoms [1][2].

At the center of this team is usually a primary care physician working alongside a metabolic geneticist (or biochemical geneticist). This specialist understands the complex chemistry of the cells and will be the primary lead for monitoring the disease itself [3][4]. Establishing a designated care coordinator can help ensure all specialists communicate effectively.

Your Essential Care Team

As you build the medical home, you will likely need to connect with the following specialists:

  • Pediatric or Adult Neurologist: Essential for managing seizures, monitoring brain development, and assessing motor skills like coordination and muscle tone [5][6].
  • Genetic Counselor: Helps you understand the FUCA1 genetic results, explains inheritance risks (the 25% recurrence risk for carrier parents) [3][7], coordinates testing for other family members, and discusses reproductive options.
  • Pulmonologist / Respiratory Therapist: Manages recurrent respiratory infections and monitors lung function, prescribing airway clearance techniques when appropriate [5][1].
  • Gastroenterologist, Nutritionist, and Feeding Specialist: Ensures adequate nutrition, evaluates swallowing safety, and monitors for organ enlargement [5][1].
  • Orthopedist: Monitors for dysostosis multiplex (skeletal changes) and helps manage mobility issues or joint stiffness [8][5].
  • Audiologist and Ophthalmologist: Baseline and symptom-driven hearing and vision checks are necessary, as fucosidosis can cause sensory changes [9][5].
  • Physical, Occupational, and Speech Therapists: These specialists are vital for maintaining comfort, communication, and the ability to move [10][11].

Preparing for a Metabolic Visit

When you visit a specialized metabolic center, gathering and organizing important records of the diagnostic journey is critical to ensure the team has all the data they need.

The Essential Document Checklist

While electronic transfers are helpful, it is important to verify that the following documents have been successfully sent and received by the new clinic:

  1. Original Lab Reports: The actual “raw” results for the alpha-L-fucosidase enzyme assay and the FUCA1 genetic sequencing, including the reference ranges and variant classifications [12][7].
  2. Imaging Files: The actual images (on a CD or digital transfer) and the written reports for any brain MRIs, spine X-rays, or abdominal ultrasounds [13][8].
  3. Urine Screen Results: The results from the urine oligosaccharide analysis [12][14].
  4. Clinical Notes: Summary notes from neurology, developmental evaluations, and any previous hospitalization records.

Collaborating with Specialists

Because fucosidosis is so rare, you may need to facilitate communication between the metabolic experts and local doctors. When meeting a prospective metabolic lead, consider asking:

  • “How many patients with fucosidosis or related glycoproteinoses (like mannosidosis) has this center followed?” [12][15]
  • “What is your center’s experience with Hematopoietic Stem Cell Transplantation (HSCT) for non-cancerous metabolic conditions?” [15][16]
  • “How do you coordinate care with the local specialists?” [2]

A center that is experienced in rare diseases will welcome these questions and collaborate to provide a “safety net” of experts ready to respond as needs change [15][17].

Common questions in this guide

Which specialists usually care for someone with fucosidosis?
A fucosidosis care team commonly includes a metabolic geneticist and primary care clinician, with neurology, respiratory, gastrointestinal, nutrition, orthopedic, hearing, and vision specialists as needed. Physical, occupational, and speech therapists can support movement, daily activities, communication, and comfort. A designated coordinator helps the team share updates.
What does a metabolic geneticist do for fucosidosis?
A metabolic geneticist leads care related to the condition’s enzyme and genetic findings and helps monitor how fucosidosis affects the body. This doctor can coordinate with local specialists and help interpret enzyme testing and FUCA1 results. The exact role may vary by clinic.
What records should I bring to a fucosidosis clinic?
Bring the original alpha-L-fucosidase enzyme test and FUCA1 genetic sequencing report, including reference ranges and the laboratory’s description of each variant. Also bring imaging files and reports, urine oligosaccharide results, neurology and developmental notes, and hospitalization records. Confirm that the new clinic received the files before the visit.
How can genetic counseling help a family affected by fucosidosis?
A genetic counselor explains what FUCA1 results mean, arranges testing for relatives, and discusses reproductive options. When both parents carry a disease-causing FUCA1 change, each pregnancy has a 25% chance of being affected. The counselor can explain how that risk applies to your family.
How do I choose a metabolic center for fucosidosis?
Ask how much experience the center has with fucosidosis and related inherited metabolic disorders. Ask how it coordinates with local doctors, responds to emergencies after hours, and supports families with school, work, insurance, or travel needs. If routine travel is difficult, ask whether telehealth is appropriate for some follow-up visits.
Who should coordinate fucosidosis care?
Choose one clearly identified care coordinator who works with the metabolic geneticist and primary care clinician. This person can help specialists share records, clarify who handles each concern, and tell the family whom to contact in an emergency. The clinic can help define this role and how to reach the coordinator.

Get notified when new evidence is published on Fucosidosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (17)
  1. 1

    Diagnosis and Supportive Management of Fucosidosis: A Case Report.

    Kaur A, Dhaliwal AS, Raynes H, et al.

    Cureus 2019; (11(11)):e6139 doi:10.7759/cureus.6139.

    PMID: 31886074
  2. 2

    The Unmet Needs of Lysosomal Storage Disorders from Early Diagnosis to Caregiving Pathways: An Italian Perspective.

    Castaman G, Linari S, Barbato A, et al.

    Journal of clinical medicine 2024; (13(22)) doi:10.3390/jcm13226981.

    PMID: 39598125
  3. 3

    An unusual presentation of fucosidosis in a Chinese boy: a case report and literature review (childhood fucosidosis).

    Mao SJ, Zhao J, Shen Z, Zou CC

    BMC pediatrics 2022; (22(1)):403 doi:10.1186/s12887-022-03414-y.

    PMID: 35820891
  4. 4

    Consensus recommendation for a diagnostic guideline for acid sphingomyelinase deficiency.

    McGovern MM, Dionisi-Vici C, Giugliani R, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2017; (19(9)):967-974 doi:10.1038/gim.2017.7.

    PMID: 28406489
  5. 5

    Novel FUCA1 variants in two families, including the first report of a contiguous gene deletion syndrome involving FUCA1 and HMGCL.

    Kılıç M, Yıldız H, Dinçsoy Bir F

    The Turkish journal of pediatrics 2025; (67(6)):896-903 doi:10.24953/turkjpediatr.2025.6009.

    PMID: 41636194
  6. 6

    Long-term outcomes in two adult siblings with Fucosidosis - Diagnostic odyssey and clinical manifestations.

    Puente-Ruiz N, Ellis I, Bregu M, et al.

    Molecular genetics and metabolism reports 2023; (37()):101009 doi:10.1016/j.ymgmr.2023.101009.

    PMID: 38053939
  7. 7

    Novel mutations in the FUCA1 gene that cause fucosidosis.

    Panmontha W, Amarinthnukrowh P, Damrongphol P, et al.

    Genetics and molecular research : GMR 2016; (15(3)) doi:10.4238/gmr.15038733.

    PMID: 27706744
  8. 8

    Skeletal and Brain Abnormalities in Fucosidosis, a Rare Lysosomal Storage Disorder.

    Malatt C, Koning JL, Naheedy J

    Journal of radiology case reports 2015; (9(5)):30-8 doi:10.3941/jrcr.v9i5.2149.

    PMID: 26622931
  9. 9

    Ocular findings in a patient with fucosidosis.

    Sánchez LR, Oatts JT, Duncan JL, et al.

    American journal of ophthalmology case reports 2016; (4()):83-86 doi:10.1016/j.ajoc.2016.10.003.

    PMID: 29503934
  10. 10

    Clinical and neuroradiological approach to fucosidosis in a child with atypical presentation.

    Zubarioglu T, Kiykim E, Zeybek CA, et al.

    Annals of Indian Academy of Neurology 2015; (18(4)):471-4 doi:10.4103/0972-2327.160090.

    PMID: 26713028
  11. 11

    Management Strategies for CLN2 Disease.

    Williams RE, Adams HR, Blohm M, et al.

    Pediatric neurology 2017; (69()):102-112 doi:10.1016/j.pediatrneurol.2017.01.034.

    PMID: 28335910
  12. 12

    A Novel Homozygous Mutation in the FUCA1 Gene Highlighting Fucosidosis as a Cause of Dystonia: Case Report and Literature Review.

    Wali G, Wali GM, Sue CM, Kumar KR

    Neuropediatrics 2019; (50(4)):248-252 doi:10.1055/s-0039-1684052.

    PMID: 31064022
  13. 13

    Longitudinal Evolution of Neuroimaging Findings in Fucosidosis: Expanding the Neuroradiologic Spectrum.

    Nikam R, Eghbal A, Sanger T, Garavatti E

    Cureus 2026; (18(7)):e112739 doi:10.7759/cureus.112739.

    PMID: 42603069
  14. 14

    MRI and MRS findings in fucosidosis; a rare lysosomal storage disease.

    Ediz SS, Aralasmak A, Yilmaz TF, et al.

    Brain & development 2016; (38(4)):435-8.

    PMID: 26515723
  15. 15

    Early Hematopoietic Stem Cell Transplantation in Type 1 Fucosidosis: Reversal of Central Tegmental Tract Abnormalities.

    Palaz M, Taşkın A, Özpınar E, et al.

    Pediatric transplantation 2026; (30(10)):e70502 doi:10.1111/petr.70502.

    PMID: 42888855
  16. 16

    Brain abnormalities in fucosidosis: transplantation or supportive therapy?

    Jiang M, Liu S, Jiang H, et al.

    Metabolic brain disease 2017; (32(2)):317-320 doi:10.1007/s11011-017-9968-5.

    PMID: 28238202
  17. 17

    Glycoproteinoses: Clinical features, therapeutic landscape, and regulatory pathways in rare lysosomal disorders.

    Casazza K, Kimonis V, Whitley CB, Jarnes JR

    Molecular genetics and metabolism 2026; (148(2)):110129 doi:10.1016/j.ymgme.2026.110129.

    PMID: 42008923

This page explains how families can organize fucosidosis care and prepare for metabolic visits for informational purposes only; it does not replace medical advice from the healthcare professionals who know your situation.